QT
STRO icon

Quantbot Technologies’s Sutro Biopharma STRO Stock Holding History

Quantbot Technologies’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.67K Buy
+201
New +$6.27K ﹤0.01% 1857
2024
Q2 		– Sell
-210
Closed -$11.9K – 1891
2024
Q1 		$11.9K Sell
210
-121
-37% -$5.34K ﹤0.01% 1450
2023
Q4 		$14.2K Buy
+331
New +$10.5K ﹤0.01% 1447
2023
Q1 		– Sell
-1,471
Closed -$119K – 2039
2022
Q4 		$119K Buy
1,471
+800
+119% +$55.6K 0.01% 1076
2022
Q3 		$37K Buy
+671
New +$39.7K ﹤0.01% 1292
2022
Q2 		– Sell
-890
Closed -$73K – 2114
2022
Q1 		$73K Buy
890
+480
+117% +$45.7K 0.01% 1112
2021
Q4 		$61K Sell
410
-70
-15% -$12.5K ﹤0.01% 980
2021
Q3 		$90K Buy
480
+390
+433% +$74.2K 0.01% 987
2021
Q2 		$16K Buy
+90
New +$17.6K ﹤0.01% 1253

Other funds holding STRO

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Quantbot Technologies's STRO Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Sutro Biopharma (STRO) in Q2 2026: 201 shares worth $6.67K. The stake represents ﹤0.01% of the portfolio and ranks #1857 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in STRO as recently as Q1 2024.

Quantbot Technologies first reported a position in STRO in Q2 2021 and has held it in 9 quarters since. The position peaked at $119K in Q4 2022. 100 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

  • Quantbot Technologies held 201 shares of Sutro Biopharma worth $6.67K as of Q2 2026.
  • Sutro Biopharma was a new Quantbot Technologies position in Q2 2026.
  • Sutro Biopharma made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1857 holding.
  • Quantbot Technologies first reported a position in Sutro Biopharma in Q2 2021 and has held it in 9 quarters since.
  • Quantbot Technologies's Sutro Biopharma position peaked at $119K in Q4 2022.
  • 100 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.